Hypercoagulable states: new knowledge about old problems.
Moake
J L
JL
Medical Hematology Section, Baylor College of Medicine, Houston.
D000293:Adolescent; D000990:Antithrombin III / Q000187:drug effects / Q000502:physiology; D001777:Blood Coagulation / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D005268:Femoral Vein; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006023:Glycoproteins / Q000096:biosynthesis / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000096:biosynthesis / Q000187:drug effects; D017293:Protein S; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D006023:Glycoproteins; D011486:Protein C; D017293:Protein S; D014859:Warfarin; D000990:Antithrombin III; D006493:Heparin